Global Personalized Medicines Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Personalized Medicines Revenue
• 1.4 Market by Type
  • 1.4.1 Global Personalized Medicines Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 PM Diagnostics
  • 1.4.3 PM Therapeutics
  • 1.4.4 Personalized Medical Care
  • 1.4.5 Personalized Nutrition & Wellness
• 1.5 Market by Application
  • 1.5.1 Global Personalized Medicines Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Dietary Care Centers
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Medicines Market Perspective (2015-2026)
• 2.2 Global Personalized Medicines Growth Trends by Regions
  • 2.2.1 Personalized Medicines Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Personalized Medicines Historic Market Share by Regions (2015-2020)
  • 2.2.3 Personalized Medicines Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Personalized Medicines Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Personalized Medicines Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Medicines Players by Market Size
  • 3.1.1 Global Top Personalized Medicines Players by Revenue (2015-2020)
  • 3.1.2 Global Personalized Medicines Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Personalized Medicines Market Concentration Ratio
  • 3.2.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2019
• 3.3 Personalized Medicines Key Players Head office and Area Served
• 3.4 Key Players Personalized Medicines Product Solution and Service
• 3.5 Date of Enter into Personalized Medicines Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Personalized Medicines Historic Market Size by Type (2015-2020)
• 4.2 Global Personalized Medicines Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Personalized Medicines Market Size by Application (2015-2020)
• 5.2 Global Personalized Medicines Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Personalized Medicines Market Size (2015-2020)
• 6.2 Personalized Medicines Key Players in North America (2019-2020)
• 6.3 North America Personalized Medicines Market Size by Type (2015-2020)
• 6.4 North America Personalized Medicines Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Personalized Medicines Market Size (2015-2020)
• 7.2 Personalized Medicines Key Players in Europe (2019-2020)
• 7.3 Europe Personalized Medicines Market Size by Type (2015-2020)
• 7.4 Europe Personalized Medicines Market Size by Application (2015-2020)

8 China

• 8.1 China Personalized Medicines Market Size (2015-2020)
• 8.2 Personalized Medicines Key Players in China (2019-2020)
• 8.3 China Personalized Medicines Market Size by Type (2015-2020)
• 8.4 China Personalized Medicines Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Personalized Medicines Market Size (2015-2020)
• 9.2 Personalized Medicines Key Players in Japan (2019-2020)
• 9.3 Japan Personalized Medicines Market Size by Type (2015-2020)
• 9.4 Japan Personalized Medicines Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Personalized Medicines Market Size (2015-2020)
• 10.2 Personalized Medicines Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Personalized Medicines Market Size by Type (2015-2020)
• 10.4 Southeast Asia Personalized Medicines Market Size by Application (2015-2020)

11 India

• 11.1 India Personalized Medicines Market Size (2015-2020)
• 11.2 Personalized Medicines Key Players in India (2019-2020)
• 11.3 India Personalized Medicines Market Size by Type (2015-2020)
• 11.4 India Personalized Medicines Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Personalized Medicines Market Size (2015-2020)
• 12.2 Personalized Medicines Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Personalized Medicines Market Size by Type (2015-2020)
• 12.4 Central & South America Personalized Medicines Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 3G Biotech
  • 13.1.1 3G Biotech Company Details
  • 13.1.2 3G Biotech Business Overview
  • 13.1.3 3G Biotech Personalized Medicines Introduction
  • 13.1.4 3G Biotech Revenue in Personalized Medicines Business (2015-2020))
  • 13.1.5 3G Biotech Recent Development
• 13.2 Quest Diagnostics
  • 13.2.1 Quest Diagnostics Company Details
  • 13.2.2 Quest Diagnostics Business Overview
  • 13.2.3 Quest Diagnostics Personalized Medicines Introduction
  • 13.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2015-2020)
  • 13.2.5 Quest Diagnostics Recent Development
• 13.3 Laboratory Corporation of America
  • 13.3.1 Laboratory Corporation of America Company Details
  • 13.3.2 Laboratory Corporation of America Business Overview
  • 13.3.3 Laboratory Corporation of America Personalized Medicines Introduction
  • 13.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2015-2020)
  • 13.3.5 Laboratory Corporation of America Recent Development
• 13.4 Abbott
  • 13.4.1 Abbott Company Details
  • 13.4.2 Abbott Business Overview
  • 13.4.3 Abbott Personalized Medicines Introduction
  • 13.4.4 Abbott Revenue in Personalized Medicines Business (2015-2020)
  • 13.4.5 Abbott Recent Development
• 13.5 Agendia NV
  • 13.5.1 Agendia NV Company Details
  • 13.5.2 Agendia NV Business Overview
  • 13.5.3 Agendia NV Personalized Medicines Introduction
  • 13.5.4 Agendia NV Revenue in Personalized Medicines Business (2015-2020)
  • 13.5.5 Agendia NV Recent Development
• 13.6 Asuragen Inc
  • 13.6.1 Asuragen Inc Company Details
  • 13.6.2 Asuragen Inc Business Overview
  • 13.6.3 Asuragen Inc Personalized Medicines Introduction
  • 13.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2015-2020)
  • 13.6.5 Asuragen Inc Recent Development
• 13.7 Becton Dickinson
  • 13.7.1 Becton Dickinson Company Details
  • 13.7.2 Becton Dickinson Business Overview
  • 13.7.3 Becton Dickinson Personalized Medicines Introduction
  • 13.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2015-2020)
  • 13.7.5 Becton Dickinson Recent Development
• 13.8 CardioDx Inc.
  • 13.8.1 CardioDx Inc. Company Details
  • 13.8.2 CardioDx Inc. Business Overview
  • 13.8.3 CardioDx Inc. Personalized Medicines Introduction
  • 13.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2015-2020)
  • 13.8.5 CardioDx Inc. Recent Development
• 13.9 Foundation Medicine
  • 13.9.1 Foundation Medicine Company Details
  • 13.9.2 Foundation Medicine Business Overview
  • 13.9.3 Foundation Medicine Personalized Medicines Introduction
  • 13.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2015-2020)
  • 13.9.5 Foundation Medicine Recent Development
• 13.10 Qiagen
  • 13.10.1 Qiagen Company Details
  • 13.10.2 Qiagen Business Overview
  • 13.10.3 Qiagen Personalized Medicines Introduction
  • 13.10.4 Qiagen Revenue in Personalized Medicines Business (2015-2020)
  • 13.10.5 Qiagen Recent Development
• 13.11 Siemens Healthcare
  • 10.11.1 Siemens Healthcare Company Details
  • 10.11.2 Siemens Healthcare Business Overview
  • 10.11.3 Siemens Healthcare Personalized Medicines Introduction
  • 10.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2015-2020)
  • 10.11.5 Siemens Healthcare Recent Development
• 13.12 Amgen
  • 10.12.1 Amgen Company Details
  • 10.12.2 Amgen Business Overview
  • 10.12.3 Amgen Personalized Medicines Introduction
  • 10.12.4 Amgen Revenue in Personalized Medicines Business (2015-2020)
  • 10.12.5 Amgen Recent Development
• 13.13 Bristol-Myers Squibb
  • 10.13.1 Bristol-Myers Squibb Company Details
  • 10.13.2 Bristol-Myers Squibb Business Overview
  • 10.13.3 Bristol-Myers Squibb Personalized Medicines Introduction
  • 10.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2015-2020)
  • 10.13.5 Bristol-Myers Squibb Recent Development
• 13.14 GE Healthcare
  • 10.14.1 GE Healthcare Company Details
  • 10.14.2 GE Healthcare Business Overview
  • 10.14.3 GE Healthcare Personalized Medicines Introduction
  • 10.14.4 GE Healthcare Revenue in Personalized Medicines Business (2015-2020)
  • 10.14.5 GE Healthcare Recent Development
• 13.15 Pfizer
  • 10.15.1 Pfizer Company Details
  • 10.15.2 Pfizer Business Overview
  • 10.15.3 Pfizer Personalized Medicines Introduction
  • 10.15.4 Pfizer Revenue in Personalized Medicines Business (2015-2020)
  • 10.15.5 Pfizer Recent Development
• 13.16 Sanofi
  • 10.16.1 Sanofi Company Details
  • 10.16.2 Sanofi Business Overview
  • 10.16.3 Sanofi Personalized Medicines Introduction
  • 10.16.4 Sanofi Revenue in Personalized Medicines Business (2015-2020)
  • 10.16.5 Sanofi Recent Development
• 13.17 23andMe
  • 10.17.1 23andMe Company Details
  • 10.17.2 23andMe Business Overview
  • 10.17.3 23andMe Personalized Medicines Introduction
  • 10.17.4 23andMe Revenue in Personalized Medicines Business (2015-2020)
  • 10.17.5 23andMe Recent Development
• 13.18 Illumina
  • 10.18.1 Illumina Company Details
  • 10.18.2 Illumina Business Overview
  • 10.18.3 Illumina Personalized Medicines Introduction
  • 10.18.4 Illumina Revenue in Personalized Medicines Business (2015-2020)
  • 10.18.5 Illumina Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer